<ѻýҕl>National Database Study Finds Higher Risk for Barrett’s Esophagus in IBDѻýҕl> But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
<ѻýҕl>FDA Approves New First-Line Standard of Care in Bladder Cancerѻýҕl> Enfortumab vedotin plus pembrolizumab doubled survival as compared with chemotherapy Dec 15, 2023
<ѻýҕl>Andre Braugher's Cancer Dx; Malignancies Rising in Younger Adults; Negative Trialsѻýҕl> News, features, and commentary about cancer-related issues Dec 14, 2023
<ѻýҕl>FDA OKs Maintenance Option for High-Risk Neuroblastomaѻýҕl> Eflornithine approved to reduce relapse risk in both kids and adults Dec 14, 2023
<ѻýҕl>'Half-Matched' BMTs Effective in Severe Sickle Cell Diseaseѻýҕl> High survival rates observed in patients not normally suitable for transplant Dec 13, 2023
<ѻýҕl>Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trialѻýҕl> Numerical advantages in OS, PFS fall short of statistical significance Dec 13, 2023
<ѻýҕl>EUS-Guided Gastroenterostomy Better Option for Cancer-Related Duodenal Blockagesѻýҕl> However, technique and technology are not widespread Dec 08, 2023
<ѻýҕl>Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drugѻýҕl> News, features, and commentary about cancer-related issues Dec 07, 2023
<ѻýҕl>Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDSѻýҕl> 40% of patients treated with imetelstat were transfusion-free for at least 8 weeks Dec 04, 2023
<ѻýҕl>First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Responseѻýҕl> A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years Dec 04, 2023
<ѻýҕl>Charting the Course: From Young Adult Leukemia Patient to Oncologistѻýҕl> My experience shaped how I care for patients today Dec 03, 2023
<ѻýҕl>Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dishѻýҕl> News, features, and commentary about cancer-related issues Dec 01, 2023
<ѻýҕl>Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancerѻýҕl> Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
<ѻýҕl>Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancerѻýҕl> Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
<ѻýҕl>Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancerѻýҕl> And our roundtable of experts discuss selinexor for wild-type p53 disease Nov 30, 2023 video
<ѻýҕl>FDA Approves First Therapy for Progressive Desmoid Tumorsѻýҕl> Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
<ѻýҕl>Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinomaѻýҕl> Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone Nov 24, 2023
<ѻýҕl>Cancer Drug Recall; Long COVID and Reinfection; WHO Staffer Killed in Gazaѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 22, 2023
<ѻýҕl>Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweensѻýҕl> Interventions worked best in combination, according to cluster randomized trial Nov 20, 2023
<ѻýҕl>Shooting at Psych Hospital; Rosalynn Carter Dies; Millions in Medical Debt Canceledѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 20, 2023
<ѻýҕl>Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Careѻýҕl> News, features, and commentary about cancer-related issues Nov 17, 2023
<ѻýҕl>Pancreatic Cancer Doesn't Have to Be a Death Sentenceѻýҕl> Early detection is the key to increasing survival rates Nov 13, 2023
<ѻýҕl>Zoonotic Spillovers; DNA and RNA Testing for Cancer Riskѻýҕl> Also in TTHealthWatch: genes and health conditions among Icelanders Nov 11, 2023 podcast
<ѻýҕl>Vitamin D for Neuropathy; Good & Bad News for CAR-T; New Labeling for Surgical Meshѻýҕl> News, features, and commentary about cancer-related issues Nov 10, 2023
<ѻýҕl>Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparitiesѻýҕl> A "local heroes effect" can better reach communities of color Nov 09, 2023
<ѻýҕl>Novel Therapies Show Early Promise in Advanced Gastroesophageal Cancersѻýҕl> Results look good, but more data needed Nov 08, 2023
<ѻýҕl>Senate Confirms Monica Bertagnolli as Next NIH Directorѻýҕl> Vote was 62-36 in favor of the current National Cancer Institute director Nov 07, 2023
<ѻýҕl>FDA Panel Backs High-Risk Designation for Salvaged Blood Irradiatorsѻýҕl> With Class III designation, sponsors would have to prove safety, efficacy with randomized trials Nov 07, 2023
<ѻýҕl>T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancersѻýҕl> More responses, longer OS in subset with the highest levels of HER2 expression Nov 07, 2023
<ѻýҕl>Maintenance Selinexor May Boost PFS in TP53 Wild-Type Advanced Endometrial Cancerѻýҕl> Particularly strong PFS signal seen in patients that were mismatch repair proficient Nov 05, 2023
<ѻýҕl>Evidence of Safety, Efficacy for Salvaged Blood Irradiators Lacking, FDA Staff Sayѻýҕl> Devices are aimed at preventing metastasis during surgery Nov 03, 2023
<ѻýҕl>Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachiaѻýҕl> News, features, and commentary about cancer-related issues Nov 03, 2023
<ѻýҕl>Transitioning Cancer Survivors Away From Oncologic Careѻýҕl> It's time for a new model of care Nov 03, 2023
<ѻýҕl>Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosisѻýҕl> Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge Nov 02, 2023
<ѻýҕl>Potential Cure for Sickle Cell Clears Hurdle for Approvalѻýҕl> FDA advisors suggest the benefits of gene therapy outweigh risks of off-target editing Oct 31, 2023
<ѻýҕl>FDA Reviewers Question Safety of Sickle Cell Gene Therapyѻýҕl> Efficacy results "strongly positive," but unintended off-target effects a question Oct 30, 2023
<ѻýҕl>FDA OKs First Drug for Nasopharyngeal Carcinomaѻýҕl> Toripalimab approved in combination with first-line chemo, and as monotherapy after progression Oct 30, 2023
<ѻýҕl>Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deathsѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 30, 2023
<ѻýҕl>Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDSѻýҕl> News, features, and commentary about cancer-related issues Oct 27, 2023
<ѻýҕl>More Data Support Adding Immunotherapy to Chemo in Advanced Endometrial Cancerѻýҕl> PFS doubled and OS improved, driven by mismatch repair-deficient disease Oct 23, 2023